Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects?
Abstract
:1. Introduction
2. Neuroprotection
3. Prevention of Eye Damage
4. Protection against Cardiovascular Injury
5. Protection against Liver Injury
6. Improvement of Energy Metabolism Disorder
7. Amelioration of Other Disorders
8. The Strategy for Developing Potential Therapy
9. Conclusions and Future Perspectives
Author Contributions
Funding
Conflicts of Interest
Abbreviations
4-HNE | 4-hydroxynonenal |
ROS | reactive oxygen species |
PARP | poly (ADP-ribose) polymerase |
PC12 cells | neuronal-like catecholaminergic cells (rat pheochromocytoma) |
Nrf-2 | nuclear factor (erythroid-derived 2)-like-2 factor |
ARE | antioxidant response elements |
Bcl-2 | B-cell lymphoma-2 |
LC3 | protein 1 light chain 3 alpha |
JNK | c-Jun-N-terminal kinase |
MAPK | mitogen-activated protein kinases |
MKK4 | mitogen-activated protein kinase kinase 4 |
NOX | NADPH oxidase |
NF-κB | nuclear factor kappa-B |
AD | Alzheimer’s disease |
AChE | acetylcholine esterase |
COX-2 | cyclooxygenase-2 |
MMP-8 | matrix metalloproteinase-8 |
CRMP-2 | collapsin response mediator protein-2 |
GST | glutathione S-transferase |
GSH-Px | glutathione peroxidase |
GR | glutathione reductase |
SOD | superoxide dismutase |
CAT | catalase |
SAMP8 | senescence-accelerated mouse prone 8 |
PD | Parkinson’s disease |
GSH | glutathione |
RPE | retinal pigment epithelium |
NLRP3 | NOD-like receptor protein 3 |
IL-1β | interleukin 1β |
AP-1 | activator protein 1 |
MCP-1 | monocyte chemotactic protein 1 |
MDA | malondialdehyde |
HO-1 | hemeoxygenase-1 |
TNF-α | tumor necrosis factor-α |
IFN-γ | interferon-γ |
AR | aldose reductase |
A2E | N-retinylidene-N-retinylethanolamine |
H9c2 cells | rat cardiomyocyte cell line |
ALDH2 | aldehyde dehydrogenase 2 |
ox-LDL | oxidized low-density lipoprotein |
MMP-1 | matrix metalloproteinase-1 |
PPARα | peroxisome proliferator-activated receptor α |
AMPK | AMP-activated protein kinase |
AKR7A2 | Aldo-Keto reductase family 7 member A2 |
hAKR1B1 | human recombinant aldose reductase |
PGC1 | peroxisome proliferator-activated receptor γ coactivator 1 |
IRS-1 | insulin receptor substrate-1 |
Akt | protein kinase B |
PKA | protein kinase A |
HSL | hormone-sensitive lipase |
HeLa | human cervical cancer |
HMEC | human microvascular endothelial cells |
HaCat | human keratinocytes |
HOS | human osteosarcoma |
LRP6 | lipoprotein receptor-related protein 6 |
MALDI-TOF/TOF | matrix-assisted laser desorption/ionization-tandem time of flight |
LC-MS/MS | liquid chromatography-tandem mass spectrometry |
References
- Dalleau, S.; Baradat, M.; Guéraud, F.; Huc, L. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 2013, 20, 1615–1630. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Breitzig, M.; Bhimineni, C.; Lockey, R.; Kolliputi, N. 4-Hydroxy-2-nonenal: A critical target in oxidative stress? Am. J. Physiol. Cell Physiol. 2016, 311, C537–C543. [Google Scholar] [CrossRef] [PubMed]
- Zarkovic, K.; Jakovcevic, A.; Zarkovic, N. Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases. Free Radic. Biol. Med. 2017, 111, 110–126. [Google Scholar] [CrossRef] [PubMed]
- Luczaj, W.; Gegotek, A.; Skrzydlewska, E. Antioxidants and HNE in redox homeostasis. Free Radic. Biol. Med. 2017, 111, 87–101. [Google Scholar] [CrossRef]
- Mali, V.R.; Palaniyandi, S.S. Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease. Free Radic. Res. 2014, 48, 251–263. [Google Scholar] [CrossRef]
- Cohen, G.; Riahi, Y.; Sunda, V.; Deplano, S.; Chatgilialoglu, C.; Ferreri, C.; Kaiser, N.; Sasson, S. Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes. Free Radic. Biol. Med. 2013, 65, 978–987. [Google Scholar] [CrossRef]
- Csala, M.; Kardon, T.; Legeza, B.; Lizák, B.; Mandl, J.; Margittai, É.; Puskás, F.; Száraz, P.; Szelényi, P.; Bánhegyi, G. On the role of 4-hydroxynonenal in health and disease. Biochim. Biophys. Acta 2015, 1852, 826–838. [Google Scholar] [CrossRef] [Green Version]
- Xiao, M.; Zhong, H.; Xia, L.; Tao, Y.; Yin, H. Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic. Biol. Med. 2017, 111, 316–327. [Google Scholar] [CrossRef]
- Rashid, S.; Ahmad, M.; Zafar, M.; Anwar, A.; Sultana, S.; Tabassum, S.; Ahmed, S.N. Ethnopharmacological evaluation and antioxidant activity of some important herbs used in traditional medicines. J. Tradit. Chin. Med. 2016, 36, 689–694. [Google Scholar] [CrossRef] [Green Version]
- Tresserra-Rimbau, A.; Lamuela-Raventos, R.M.; Moreno, J.J. Polyphenols, food and pharma. Current knowledge and directions for future research. Biochem. Pharmacol. 2018, 156, 186–195. [Google Scholar] [CrossRef]
- Olszowy, M. What is responsible for antioxidant properties of polyphenolic compounds from plants? Plant Physiol. Biochem. 2019, 144, 135–143. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Qi, W.; Huo, Y.; Song, G.; Sun, H.; Guo, X.; Wang, C. Cyanidin-3-glucoside attenuates 4-hydroxynonenal- and visible light-induced retinal damage in vitro and in vivo. Food Funct. 2019, 10, 2871–2880. [Google Scholar] [CrossRef] [PubMed]
- Jang, Y.J.; Kim, J.; Shim, J.; Kim, J.; Byun, S.; Oak, M.H.; Lee, K.W.; Lee, H.J. Kaempferol attenuates 4-hydroxynonenal-induced apoptosis in PC12 cells by directly inhibiting NADPH oxidase. J. Pharmacol. Exp. Ther. 2011, 337, 747–754. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Miller, D.M.; Singh, I.N.; Wang, J.A.; Hall, E.D. Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radic. Biol. Med. 2013, 57, 1–9. [Google Scholar] [CrossRef] [Green Version]
- Hortigon-Vinagre, M.P.; Blanco, J.; Ruiz, T.; Henao, F. Thymbra capitata essential oil prevents cell death induced by 4-hydroxy-2-nonenal in neonatal rat cardiac myocytes. Planta Med. 2014, 80, 1284–1290. [Google Scholar] [CrossRef]
- Liu, K.L.; Kuo, W.C.; Lin, C.Y.; Lii, C.K.; Liu, Y.L.; Cheng, Y.H.; Tsai, C.W. Prevention of 4-hydroxynonenal-induced lipolytic activation by carnosic acid is related to the induction of glutathione S-transferase in 3T3-L1 adipocytes. Free Radic. Biol. Med. 2018, 121, 1–8. [Google Scholar] [CrossRef]
- Neely, M.D.; Boutte, A.; Milatovic, D.; Montine, T.J. Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Res. 2005, 1037, 90–98. [Google Scholar] [CrossRef]
- Caruana, M.; Cauchi, R.; Vassallo, N. Putative role of red wine polyphenols against brain pathology in Alzheimer’s and Parkinson’s disease. Front. Nutr. 2016, 3, 00031. [Google Scholar] [CrossRef] [Green Version]
- Jang, Y.J.; Kang, N.J.; Lee, K.W.; Lee, H.J. Protective effects of red wine flavonols on 4-hydroxynonenal-induced apoptosis in PC12 cells. Ann. N. Y. Acad. Sci. 2009, 1171, 170–175. [Google Scholar] [CrossRef]
- Elumalai, P.; Lakshmi, S. Role of quercetin benefits in neurodegeneration. Adv. Neurobiol. 2016, 12, 229–245. [Google Scholar]
- Joshi, V.; Mishra, R.; Upadhyay, A.; Amanullah, A.; PoluriK, M.; Singh, S.; Kumar, A.; Mishra, A. Polyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregation. J. Cell Physiol. 2019, 234, 20900–20914. [Google Scholar] [CrossRef] [PubMed]
- Wu, P.S.; Yen, J.H.; Kou, M.C.; Wu, M.J. Luteolin and apigenin attenuate 4-hydroxy-2-nonenal-mediated cell death through modulation of UPR, Nrf2-ARE and MAPK pathways in PC12 cells. PLoS ONE 2015, 10, e0130599. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Singhal, S.S.; Singh, S.P.; Singhal, P.; Horne, D.; Singhal, J.; Awasthi, S. Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling. Toxicol. Appl. Pharmacol. 2015, 289, 361–370. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, W.; Kato, M.; Akhand, A.A.; Hayakawa, A.; Suzuki, H.; Miyata, T.; Kurokawa, K.; Hotta, Y.; Ishikawa, N.; Nakashima, I. 4-Hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J. Cell Sci. 2000, 113, 635–641. [Google Scholar] [PubMed]
- Jang, Y.J.; Kim, J.E.; Kang, N.J.; Lee, K.W.; Lee, H.J. Piceatannol attenuates 4-hydroxynonenal-induced apoptosis of PC12 cells by blocking activation of c-Jun N-terminal kinase. Ann. N. Y. Acad. Sci. 2009, 1171, 176–182. [Google Scholar] [CrossRef]
- Dumont, U.; Sanchez, S.; Olivier, B.; Chateil, J.F.; Pellerin, L.; Beauvieux, M.C.; Bouzier-Sore, A.K.; Roumes, H. Maternal consumption of piceatannol: A nutritional neuroprotective strategy against hypoxia-ischemia in rat neonate. Brain Res. 2019, 1717, 86–94. [Google Scholar] [CrossRef]
- Ye, Y.J.; Kim, Y.S.; Kang, M.S. Effects of citri reticulatae viride pericarpium on 4-hydroxynonenal-induced inflammation in PC12 cells. J. Korean Med. Obes. Res. 2016, 16, 79–84. [Google Scholar] [CrossRef] [Green Version]
- Cho, E.S.; Jang, Y.J.; Kang, N.J.; Hwang, M.K.; Kim, Y.T.; Lee, K.W.; Lee, H.J. Cocoa procyanidins attenuate 4-hydroxynonenal-induced apoptosis of PC12 cells by directly inhibiting mitogen-activated protein kinase kinase 4 activity. Free Radic. Biol. Med. 2009, 46, 1319–1327. [Google Scholar] [CrossRef]
- Nguyen, T.; Nioi, P.; Pickett, C.B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 2009, 284, 13291–13295. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Siddiqui, M.A.; Kashyap, M.P.; Kumar, V.; Al-Khedhairy, A.A.; Musarrat, J.; Pant, A.B. Protective potential of trans-resveratrol against 4-hydroxynonenal induced damage in PC12 cells. Toxicol. In Vitro 2010, 24, 1592–1598. [Google Scholar] [CrossRef] [PubMed]
- Hernandes, M.S.; D’Avila, J.C.; Trevelin, S.C.; Reis, P.A.; Kinjo, E.R.; Lopes, L.R.; Castro-Faria-Neto, H.C.; Cunha, F.Q.; Britto, L.R.; Bozza, F.A. The role of Nox2-derived ROS in the development of cognitive impairment after sepsis. J. Neuroinflamm. 2014, 11, 36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sun, J.B.; Li, Y.; Cai, Y.F.; Huang, Y.; Liu, S.; Yeung, P.K.; Deng, M.Z.; Sun, G.S.; Zilundu, P.L.; Hu, Q.S.; et al. Scutellarin protects oxygen/glucose-deprived astrocytes and reduces focal cerebral ischemic injury. Neural Regen. Res. 2018, 13, 1396–1407. [Google Scholar] [PubMed]
- Di Domenico, F.; Tramutola, A.; Butterfield, D.A. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders. Free Radic. Biol. Med. 2017, 111, 253–261. [Google Scholar] [CrossRef] [PubMed]
- Benedetti, E.; D’Angelo, B.; Cristiano, L.; Di Giacomo, E.; Fanelli, F.; Moreno, S.; Cecconi, F.; Fidoamore, A.; Antonosante, A.; Falcone, R.; et al. Involvement of peroxisome proliferator-activated receptor β/δ (PPAR β/δ) in BDNF signaling during aging and in Alzheimer disease: Possible role of 4-hydroxynonenal (4-HNE). Cell Cycle 2014, 13, 1335–1344. [Google Scholar] [CrossRef]
- Rasool, M.; Malik, A.; Waquar, S.; Tul-Ain, Q.; Jafar, T.H.; Rasool, R.; Kalsoom, A.; Ghafoor, M.A.; Sehgal, S.A.; Gauthaman, K.; et al. In-Silico characterization and in-vivo validation of albiziasaponin-A, iso-orientin, and salvadorin using a rat model of Alzheimer’s disease. Front. Pharmacol. 2018, 9, 730. [Google Scholar] [CrossRef]
- Curtis, J.M.; Grimsrud, P.A.; Wright, W.S.; Xu, X.; Foncea, R.E.; Graham, D.W.; Brestoff, J.R.; Wiczer, B.M.; Ilkayeva, O.; Cianflone, K.; et al. Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 2010, 59, 1132–1142. [Google Scholar] [CrossRef] [Green Version]
- Ghofrani, S.; Joghataei, M.T.; Mohseni, S.; Baluchnejadmojarad, T.; Bagheri, M.; Khamse, S.; Roghani, M. Naringenin improves learning and memory in an Alzheimer’s disease rat model: Insights into the underlying mechanisms. Eur. J. Pharmacol. 2015, 764, 195–201. [Google Scholar] [CrossRef] [Green Version]
- Khan, M.B.; Khan, M.M.; Khan, A.; Ahmed, M.E.; Ishrat, T.; Tabassum, R.; Vaibhav, K.; Ahmad, A.; Islam, F. Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model. Neurochem. Int. 2012, 61, 1081–1093. [Google Scholar] [CrossRef]
- Lawal, M.F.; Olotu, F.A.; Agoni, C.; Soliman, M.E. Exploring the C-terminal tail dynamics: Structural and molecular perspectives into the therapeutic activities of novel CRMP-2 inhibitors, naringenin and naringenin-7-O-glucuronide, in the treatment of Alzheimer’s disease. Chem. Biodivers. 2018, 15, e1800437. [Google Scholar] [CrossRef]
- Lawal, M.; Olotu, F.A.; Soliman, M.E.S. Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer’s disease using bioinformatics and computational tools. Comput. Biol. Med. 2018, 98, 168–177. [Google Scholar] [CrossRef]
- Farr, S.A.; Niehoff, M.L.; Ceddia, M.A.; Herrlinger, K.A.; Lewis, B.J.; Feng, S.L.; Welleford, A.; Butterfield, D.A.; Morley, J.E. Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice. Physiol. Behav. 2016, 165, 328–338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kantar Gok, D.; Hidisoglu, E.; Ocak, G.A.; Er, H.; Acun, A.D.; Yargıcoglu, P. Protective role of rosmarinic acid on amyloid beta 42-induced echoic memory decline: Implication of oxidative stress and cholinergic impairment. Neurochem. Int. 2018, 118, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Cai, S.; Yang, H.; Wen, B.; Zhu, K.; Zheng, X.; Huang, J.; Wang, Y.; Liu, Z.; Tu, P. Inhibition by microbial metabolites of Chinese dark tea of age-related neurodegenerative disorders in senescence-accelerated mouse prone 8 (SAMP8) mice. Food Funct. 2018, 9, 5455–5462. [Google Scholar] [CrossRef] [PubMed]
- Goes, A.T.R.; Jesse, C.R.; Antunes, M.S.; Lobo Ladd, F.V.; Lobo Ladd, A.A.B.; Luchese, C.; Paroul, N.; Boeira, S.P. Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson’s disease: Involvement of neuroinflammation and neurotrophins. Chem. Biol. Interact. 2018, 279, 111–120. [Google Scholar] [CrossRef] [PubMed]
- Lv, C.; Hong, T.; Yang, Z.; Zhang, Y.; Wang, L.; Dong, M.; Zhao, J.; Mu, J.; Meng, Y. Effect of quercetin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse model of Parkinson’s disease. Evid. Based Complement. Alternat. Med. 2012, 2012, 928643. [Google Scholar] [CrossRef]
- Deng, R.; Hua, X.; Li, J.; Chi, W.; Zhang, Z.; Lu, F.; Zhang, L.; Pflugfelder, S.C.; Li, D.Q. Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells. PLoS ONE 2015, 10, e0126561. [Google Scholar] [CrossRef] [Green Version]
- Seen, S.; Tong, L. Dry eye disease and oxidative stress. Acta Ophthalmol. 2018, 96, E412–E420. [Google Scholar] [CrossRef] [Green Version]
- Raman, T.; Ramar, M.; Arumugam, M.; Nabavi, S.M.; Varsha, M.K. Cytoprotective mechanism of action of curcumin against cataract. Pharmacol. Rep. 2016, 68, 561–569. [Google Scholar] [CrossRef]
- Chen, J.; Wang, L.; Chen, Y.; Sternberg, P.; Cai, J. Phosphatidylinositol 3 kinase pathway and 4-hydroxy-2-nonenal-induced oxidative injury in the RPE. Investig. Ophthalmol. Vis. Sci. 2009, 50, 936–942. [Google Scholar] [CrossRef]
- Vatsyayan, R.; Chaudhary, P.; Sharma, A.; Sharma, R.; Rao Lelsani, P.C.; Awasthi, S.; Awasthi, Y.C. Role of 4-hydroxynonenal in epidermal growth factor receptor-mediated signaling in retinal pigment epithelial cells. Exp. Eye Res. 2011, 92, 147–154. [Google Scholar] [CrossRef] [Green Version]
- Choi, W.; Lee, J.B.; Cui, L.; Li, Y.; Li, Z.R.; Choi, J.S.; Lee, H.S.; Yoon, K.C. Therapeutic efficacy of topically applied antioxidant medicinal plant extracts in a mouse model of experimental dry eye. Oxid. Med. Cell Longev. 2016, 2016, 4727415. [Google Scholar] [CrossRef] [PubMed]
- Chang, K.C.; Shieh, B.; Petrash, J.M. Role of aldose reductase in diabetes-induced retinal microglia activation. Chem. Biol. Interact. 2019, 302, 46–52. [Google Scholar] [CrossRef] [PubMed]
- Lu, Q.; Hao, M.; Wu, W.Y.; Zhang, N.; Isaac, A.T.; Yin, J.L.; Zhu, X.; Du, L.; Yin, X.X. Antidiabetic cataract effects of GbE, rutin and quercetin are mediated by the inhibition of oxidative stress and polyol pathway. Acta Biochim. Pol. 2018, 65, 35–41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Feng, X.; Sureda, A.; Jafari, S.; Memariani, Z.; Tewari, D.; Annunziata, G.; Barrea, L.; Hassan, S.T.S.; Smejkal, K.; Malanik, M.; et al. Berberine in cardiovascular and metabolic diseases: From mechanisms to therapeutics. Theranostics 2019, 9, 1923–1951. [Google Scholar] [CrossRef]
- Yang, S.H.; Wu, M.Y.; Fu, D.X.; Chen, J.P.; Zhang, J.; Wilson, K.; Elliot, M.; Du, M.; Lyo, T. Berberine acts as a novel autophagy blocker to protect human müLler cell from 4-hne induced cell death. Investig. Ophthalmol. Vis. Sci. 2012, 53, 2019. [Google Scholar]
- Yu, C.C.; Nandrot, E.F.; Dun, Y.; Finnemann, S.C. Dietary antioxidants prevent age-related retinal pigment epithelium actin damage and blindness in mice lacking alpha v beta 5 integrin. Free Radic. Biol. Med. 2012, 52, 660–670. [Google Scholar] [CrossRef] [Green Version]
- Xu, D.; Hu, M.J.; Wang, Y.Q.; Cui, Y.L. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules 2019, 24, 1123. [Google Scholar] [CrossRef] [Green Version]
- Hytti, M.; Piippo, N.; Salminen, A.; Honkakoski, P.; Kaarniranta, K.; Kauppinen, A. Quercetin alleviates 4-hydroxynonenal-induced cytotoxicity and inflammation in ARPE-19 cells. Exp. Eye Res. 2015, 132, 208–215. [Google Scholar] [CrossRef]
- Shao, Y.; Yu, H.; Yang, Y.; Li, M.; Hang, L.; Xu, X. A solid dispersion of quercetin shows enhanced Nrf2 activation and protective effects against oxidative injury in a mouse model of dry age-related macular degeneration. Oxid. Med. Cell. Longev. 2019, 2019, 1479571. [Google Scholar] [CrossRef]
- Wang, Y.; Kim, H.J.; Sparrow, J.R. Quercetin and cyanidin-3-glucoside protect against photooxidation and photodegradation of A2E in retinal pigment epithelial cells. Exp. Eye Res. 2017, 160, 45–55. [Google Scholar] [CrossRef]
- Yu, M.Z.; Yan, W.M.; Beight, C. Lutein and zeaxanthin isomers protect against light-induced retinopathy via decreasing oxidative and endoplasmic reticulum stress in BALB/cJ mice. Nutrients 2018, 10, 842. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tseng, W.A.; Thein, T.; Kinnunen, K.; Lashkari, K.; Gregory, M.S.; D’Amore, P.A.; Ksander, B.R. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: Implications for age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2013, 54, 110–120. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Huo, Y.Z.; Zhao, L.; Lu, F.; Wang, O.; Yang, X.; Ji, B.P.; Zhou, F. Cyanidin-3-glucoside and its phenolic acid metabolites attenuate visible light-induced retinal degeneration in vivo via activation of Nrf2/HO-1 pathway and NF-κB suppression. Mol. Nutr. Food Res. 2016, 60, 1564–1577. [Google Scholar] [CrossRef] [PubMed]
- Jin, X.L.; Wang, C.T.; Wu, W.; Liu, T.T.; Ji, B.P.; Zhou, F. Cyanidin-3-glucoside alleviates 4-hydroxyhexenal-induced NLRP3 inflammasome activation via JNK-c-Jun/AP-1 pathway in human retinal pigment epithelial cells. J. Immunol. Res. 2018, 2018, 5604610. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cheng, S.C.; Huang, W.C.; JH, S.P.; Wu, Y.H.; Cheng, C.Y. Quercetin inhibits the production of IL-1beta-induced inflammatory cytokines and chemokines in ARPE-19 cells via the MAPK and NF-kappaB signaling pathways. Int. J. Mol. Sci. 2019, 20, 2957. [Google Scholar] [CrossRef] [Green Version]
- Chapple, S.J.; Cheng, X.; Mann, G.E. Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease. Redox Biol. 2013, 1, 319–331. [Google Scholar] [CrossRef] [Green Version]
- Phaniendra, A.; Jestadi, D.B.; Periyasamy, L. Free radicals: Properties, sources, targets, and their implication in various diseases. Indian J. Clin. Biochem. 2015, 30, 11–26. [Google Scholar] [CrossRef] [Green Version]
- Bali, E.B.; Ergin, V.; Rackova, L.; Bayraktar, O.; Kucukboyaci, N.; Karasu, C. Olive leaf extracts protect cardiomyocytes against 4-hydroxynonenal-induced toxicity in vitro: Comparison with oleuropein, hydroxytyrosol, and quercetin. Planta Med. 2014, 80, 984–992. [Google Scholar] [CrossRef] [Green Version]
- Othman, A.I.; El-Sawi, M.R.; El-Missiry, M.A.; Abukhalil, M.H. Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats. Biomed. Pharmacother. 2017, 94, 362–373. [Google Scholar] [CrossRef]
- Xin, Y.; Bai, Y.; Jiang, X.; Zhou, S.; Wang, Y.; Wintergerst, K.A.; Cui, T.; Ji, H.; Tan, Y.; Cai, L. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway. Redox Biol. 2018, 15, 405–417. [Google Scholar] [CrossRef]
- Liu, B.; Zhao, C.; Li, H.; Chen, X.; Ding, Y.; Xu, S. Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis. Biochem. Biophys. Res. Commun. 2018, 497, 233–240. [Google Scholar] [CrossRef] [PubMed]
- He, L.; Liu, B.; Dai, Z.; Zhang, H.F.; Zhang, Y.S.; Luo, X.J.; Ma, Q.L.; Peng, J. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. Eur. J. Pharmacol. 2012, 678, 32–328. [Google Scholar] [CrossRef] [PubMed]
- Kurumazuka, D.; Kitada, K.; Tanaka, R.; Mori, T.; Ohkita, M.; Takaoka, M.; Matsumura, Y. α-Lipoic acid exerts a primary prevention for the cardiac dysfunction in aortocaval fistula-created rat hearts. Heliyon 2019, 5, e02371. [Google Scholar] [CrossRef] [PubMed]
- Jiang, W.B.; Zhao, W.; Chen, H.; Wu, Y.Y.; Wang, Y.; Fu, G.S.; Yang, X.J. Baicalin protects H9c2 cardiomyocytes against hypoxia/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2. Clin. Exp. Pharmacol. Physiol. 2018, 45, 303–311. [Google Scholar] [CrossRef] [PubMed]
- Negre-Salvayre, A.; Garoby-Salom, S.; Swiader, A.; Rouahi, M.; Pucelle, M.; Salvayre, R. Proatherogenic effects of 4-hydroxynonenal. Free Radic. Biol. Med. 2017, 111, 127–139. [Google Scholar] [CrossRef]
- Akiba, S.; Yamaguchi, H.; Kumazawa, S.; Oka, M.; Sato, T. Suppression of oxidized LDL-induced PDGF receptor beta activation by Ginkgo biloba extract reduces MMP-1 production in coronary smooth muscle cells. J. Atheroscler. Thromb. 2007, 14, 219–225. [Google Scholar] [CrossRef] [Green Version]
- Keller, J.; Camaré, C.; Bernis, C.; Astello-García, M.; de la Rosa, A.P.; Rossignol, M.; del Socorro Santos Díaz, M.; Salvayre, R.; Negre-Salvayre, A.; Guéraud, F. Antiatherogenic and antitumoral properties of Opuntia cladodes: Inhibition of low density lipoprotein oxidation by vascular cells, and protection against the cytotoxicity of lipid oxidation product 4-hydroxynonenal in a colorectal cancer cellular model. J. Physiol. Biochem. 2015, 71, 577–587. [Google Scholar] [CrossRef]
- Garoby-Salom, S.; Guéraud, F.; Camaré, C.; de la Rosa, A.P.; Rossignol, M.; Santos Díaz Mdel, S.; Salvayre, R.; Negre-Salvayre, A. Dietary cladode powder from wild type and domesticated Opuntia species reduces atherogenesis in apoE knock-out mice. J. Physiol. Biochem. 2016, 72, 59–70. [Google Scholar] [CrossRef]
- Shearn, C.T.; Reigan, P.; Petersen, D.R. Inhibition of hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells. Free Radic. Biol. Med. 2012, 53, 1–11. [Google Scholar] [CrossRef] [Green Version]
- Seo, B.Y.; Choi, M.J.; Kim, J.S.; Park, E. Comparative analysis of ginsenoside profiles: Antioxidant, antiproliferative, and antigenotoxic activities of Ginseng extracts of gine and main roots. Prev. Nutr. Food Sci. 2019, 24, 128–135. [Google Scholar] [CrossRef]
- Kim, H.G.; Jang, S.S.; Lee, J.S.; Kim, H.S.; Son, C.G. Panax ginseng Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis. J. Ginseng Res. 2017, 41, 159–168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Han, J.Y.; Lee, S.; Yang, J.H.; Kim, S.; Sim, J.; Kim, M.G.; Jeong, T.C.; Ku, S.K.; Cho, I.J.; Ki, S.H. Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activation. J. Ginseng Res. 2015, 39, 105–115. [Google Scholar] [CrossRef] [Green Version]
- Choudhry, Q.N.; Kim, J.H.; Cho, H.T.; Heo, W.; Lee, J.J.; Lee, J.H.; Kim, Y.J. Ameliorative effect of black ginseng extract against oxidative stress-induced cellular damages in mouse hepatocytes. J. Ginseng Res. 2019, 43, 179–185. [Google Scholar] [CrossRef] [PubMed]
- Xu, X.Y.; Wang, Z.; Ren, S.; Leng, J.; Hu, J.N.; Liu, Z.; Chen, C.; Li, W. Improved protective effects of American ginseng berry against acetaminophen-induced liver toxicity through TNF-α-mediated caspase-3/-8/-9 signaling pathways. Phytomedicine 2018, 51, 128–138. [Google Scholar] [CrossRef] [PubMed]
- Qian, Q.Y.; Ying, N.; Yang, Z.; Zhou, L.; Liu, Q.S.; Hu, Z.Y.; Fan, C.L.; Li, S.T.; Dou, X.B. Mechanisms of tanshinone Ⅱ_A in reducing 4-HNE-induced hepatocyte damage by activating PPARα. Zhongguo Zhong Yao Za Zhi 2019, 44, 1862–1868. (In Chinese) [Google Scholar]
- Sundarraj, K.; Raghunath, A.; Perumal, E. A review on the chemotherapeutic potential of fisetin: In vitro evidences. Biomed. Pharmacother. 2018, 97, 928–940. [Google Scholar] [CrossRef]
- Yousefzadeh, M.J.; Zhu, Y.; McGowan, S.J.; Angelini, L.; Fuhrmann-Stroissnigg, H.; Xu, M.; Ling, Y.Y.; Melos, K.I.; Pirtskhalava, T.; Inman, C.L.; et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 2018, 36, 18–28. [Google Scholar] [CrossRef] [Green Version]
- Cha, H.; Lee, S.; Lee, J.H.; Park, J.W. Protective effects of p-coumaric acid against acetaminophen-induced hepatotoxicity in mice. Food Chem. Toxicol. 2018, 121, 131–139. [Google Scholar] [CrossRef]
- Seo, H.L.; Baek, S.Y.; Lee, E.H.; Lee, J.H.; Lee, S.G.; Kim, K.Y.; Jang, M.H.; Park, M.H.; Kim, J.H.; Kim, K.J.; et al. Liqustri lucidi Fructus inhibits hepatic injury and functions as an antioxidant by activation of AMP-activated protein kinase in vivo and in vitro. Chem. Biol. Interact. 2017, 262, 57–68. [Google Scholar] [CrossRef]
- Li, D.; Gu, Z.; Zhang, J.; Ma, S. Protective effect of inducible aldo-keto reductases on 4-hydroxynonenal-induced hepatotoxicity. Chem. Biol. Interact. 2019, 304, 124–130. [Google Scholar] [CrossRef]
- Balestri, F.; De Leo, M.; Sorce, C.; Cappiello, M.; Quattrini, L.; Moschini, R.; Pineschi, C.; Braca, A.; La Motta, C.; Da Settimo, F.; et al. Soyasaponins from Zolfino bean as aldose reductase differential inhibitors. J. Enzyme Inhib. Med. Chem. 2019, 34, 350–360. [Google Scholar] [CrossRef] [PubMed]
- Elrayess, M.A.; Almuraikhy, S.; Kafienah, W.; Al Menhali, A.; Al-Khelaifi, F.; Bashah, M.; Zarkovic, K.; Zarkovic, N.; Waeg, G.; Alsayrafi, M.; et al. 4-Hydroxynonenal causes impairment of human subcutaneous adipogenesis and induction of adipocyte insulin resistance. Free Radic. Biol. Med. 2017, 104, 129–137. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pillon, N.J.; Croze, M.L.; Vella, R.E.; Soulere, L.; Lagarde, M.; Soulage, C.O. The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress. Endocrinology 2012, 153, 2099–2111. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; Dou, X.; Gu, D.; Shen, C.; Yao, T.; Nguyen, V.; Braunschweig, C.; Song, Z. 4-Hydroxynonenal differentially regulates adiponectin gene expression and secretion via activating PPARgamma and accelerating ubiquitin-proteasome degradation. Mol. Cell Endocrinol. 2012, 349, 222–231. [Google Scholar] [CrossRef] [Green Version]
- Killion, E.A.; Reeves, A.R.; El Azzouny, M.A.; Yan, Q.W.; Surujon, D.; Griffin, J.D.; Bowman, T.A.; Wang, C.; Matthan, N.R.; Klett, E.L.; et al. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction. Mol. Metab. 2018, 9, 43–56. [Google Scholar] [CrossRef]
- Guo, L.; Zhang, X.M.; Zhang, Y.B.; Huang, X.; Chi, M.H. Association of 4-hydroxynonenal with classical adipokines and insulin resistance in a Chinese non-diabetic obese population. Nutr. Hosp. 2017, 34, 363–368. [Google Scholar] [CrossRef]
- Lee, H.; Lim, Y. Tocotrienol-rich fraction supplementation reduces hyperglycemia-induced skeletal muscle damage through regulation of insulin signaling and oxidative stress in type 2 diabetic mice. J. Nutr. Biochem. 2018, 57, 77–85. [Google Scholar] [CrossRef]
- Mahboubi, M. Morus alba (mulberry), a natural potent compound in management of obesity. Pharmacol. Res. 2019, 146, 104341. [Google Scholar] [CrossRef]
- Kavitha, Y.; Geetha, A. Anti-inflammatory and preventive activity of white mulberry root bark extract in an experimental model of pancreatitis. J. Tradit. Complement. Med. 2018, 8, 497–505. [Google Scholar] [CrossRef]
- Adisakwattana, S.; Intrawangso, J.; Hemrid, A.; Chanathong, B.; Makynen, K. Extracts of edible plants inhibit pancreatic lipase, cholesterol esterase and cholesterol micellization, and bind bile acids. Food Technol. Biotechnol. 2012, 50, 11–16. [Google Scholar]
- Ann, J.Y.; Eo, H.; Lim, Y. Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice. Genes Nutr. 2015, 10, 46. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Singh, C.K.; Kumar, A.; Lavoie, H.A.; Dipette, D.J.; Singh, U.S. Diabetic complications in pregnancy: Is resveratrol a solution? Exp. Biol. Med. 2013, 238, 482–490. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Al-Hussaini, H.; Kilarkaje, N. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys. Toxicol. Appl. Pharmacol. 2018, 339, 97–109. [Google Scholar] [CrossRef]
- Sukumar, P.; Viswambharan, H.; Imrie, H.; Cubbon, R.M.; Yuldasheva, N.; Gage, M.; Galloway, S.; Skromna, A.; Kandavelu, P.; Santos, C.X.; et al. Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes 2013, 62, 2130–2134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mahmoud, A.M.; Ali, M.M.; Miranda, E.R.; Mey, J.T.; Blackburn, B.K.; Haus, J.M.; Phillips, S.A. Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function. Redox Biol. 2017, 13, 288–300. [Google Scholar] [CrossRef] [PubMed]
- Cremonini, E.; Wang, Z.; Bettaieb, A.; Adamo, A.M.; Daveri, E.; Mills, D.A.; Kalanetra, K.M.; Haj, F.G.; Karakas, S.; Oteiza, P.I. (−)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: Implications for steatosis and insulin resistance. Redox Biol. 2018, 14, 588–599. [Google Scholar] [CrossRef] [PubMed]
- Daveri, E.; Cremonini, E.; Mastaloudis, A.; Hester, S.N.; Wood, S.M.; Waterhouse, A.L.; Anderson, M.; Fraga, C.G.; Oteiza, P.I. Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice. Redox Biol. 2018, 18, 16–24. [Google Scholar] [CrossRef] [PubMed]
- Yang, B.Y.; Guo, Y.; Markevych, I.; Qian, Z.M.; Bloom, M.S.; Heinrich, J.; Dharmage, S.C.; Rolling, C.A.; Jordan, S.S.; Komppula, M.; et al. Association of long-term exposure to ambient air pollutants with risk factors for cardiovascular disease in China. JAMA Netw. Open 2019, 2, e190318. [Google Scholar] [CrossRef] [Green Version]
- De Bont, J.; Casas, M.; Barrera-Gomez, J.; Cirach, M.; Rivas, I.; Valvi, D.; Alvarez, M.; Dadvand, P.; Sunyer, J.; Vrijheid, M. Ambient air pollution and overweight and obesity in school-aged children in Barcelona, Spain. Environ. Int. 2019, 125, 58–64. [Google Scholar] [CrossRef]
- Lucht, S.; Hennig, F.; Moebus, S.; Fuhrer-Sakel, D.; Herder, C.; Jockel, K.H.; Hoffmann, B.; Heinz, G. Air pollution and diabetes-related biomarkers in non-diabetic adults: A pathway to impaired glucose metabolism? Environ. Int. 2019, 124, 370–392. [Google Scholar] [CrossRef]
- Wang, N.; Ma, Y.; Liu, Z.; Liu, L.; Yang, K.; Wei, Y.; Liu, Y.; Chen, X.; Sun, X. and Wen, D. Hydroxytyrosol prevents PM2.5-induced adiposity and insulin resistance by restraining oxidative stress related NF-kappaB pathway and modulation of gut microbiota in a murine model. Free Radic. Biol. Med. 2019, 141, 393–407. [Google Scholar] [CrossRef]
- Gallo, G.; Bruno, R.; Taranto, A.; Martino, G. Are polyunsaturated fatty acid metabolites, the protective effect of 4-hydroxytyrosol on human red blood cell membranes and oxidative damage (4-hydroxyalkenals) compatible in hypertriglyceridemic patients? Pharmacogn. Mag. 2017, 13, S561–S566. [Google Scholar] [CrossRef] [PubMed]
- Cesar, V.; Jozić, I.; Begović, L.; Vuković, T.; Mlinarić, S.; Lepeduš, H.; Borović Šunjić, S.; Žarković, N. Cell-type-specific modulation of hydrogen peroxide cytotoxicity and 4-hydroxynonenal binding to human cellular proteins in vitro by antioxidant Aloe vera extract. Antioxidants 2018, 7, 125. [Google Scholar] [CrossRef] [Green Version]
- Cheng, P.; Kuang, F.; Ju, G. Aescin reduces oxidative stress and provides neuroprotection in experimental traumatic spinal cord injury. Free Radic. Biol. Med. 2016, 99, 405–417. [Google Scholar] [CrossRef] [PubMed]
- Sirtori, C.R. Aescin: Pharmacology, pharmacokinetics and therapeutic profile. Pharmacol. Res. 2001, 44, 183–193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, Q.; Lin, F.Q.; Wang, S.Q.; Hong, W.S.; Xu, A. Protective capacity of five kinds of plant extracts on 4HNE-induced melanocyte. Chin. Arch. Tradit. Chin. Med. 2015, 33, 1610–1613. [Google Scholar]
- Gegotek, A.; Bielawska, K.; Biernacki, M.; Dobrzynska, I.; Skrzydlewska, E. Time-dependent effect of rutin on skin fibroblasts membrane disruption following UV radiation. Redox Biol. 2017, 12, 733–744. [Google Scholar] [CrossRef]
- Gegotek, A.; Bielawska, K.; Biernacki, M.; Zareba, I.; Surazynski, A.; Skrzydlewska, E. Comparison of protective effect of ascorbic acid on redox and endocannabinoid systems interactions in in vitro cultured human skin fibroblasts exposed to UV radiation and hydrogen peroxide. Arch. Dermatol. Res. 2017, 309, 285–303. [Google Scholar] [CrossRef] [Green Version]
- Yamaguchi, T.; Yoneyama, M.; Hinoi, E.; Ogita, K. Involvement of calpain in 4-hydroxynonenal-induced disruption of gap junction-mediated intercellular communication among fibrocytes in primary cultures derived from the cochlear spiral ligament. J. Pharmacol. Sci. 2015, 129, 127–134. [Google Scholar] [CrossRef] [Green Version]
- Castaneda, R.; Natarajan, S.; Jeong, S.Y.; Hong, B.N.; Kang, T.H. Traditional oriental medicine for sensorineural hearing loss: Can ethnopharmacology contribute to potential drug discovery? J. Ethnopharmacol. 2018, 231, 409–428. [Google Scholar] [CrossRef]
- Xiong, M.; He, Q.L.; Lai, H.W.; Wang, J. Astragaloside IV inhibits apoptotic cell death in the guinea pig cochlea exposed to impulse noise. Acta Otolaryngol. 2012, 132, 467–474. [Google Scholar] [CrossRef] [PubMed]
- Xiong, M.; Lai, H.; He, Q.; Wang, J. Astragaloside IV attenuates impulse noise-induced trauma in guinea pig. Acta Otolaryngol. 2011, 131, 809–816. [Google Scholar] [CrossRef] [PubMed]
- Fetoni, A.R.; Paciello, F.; Rolesi, R.; Eramo, S.L.M.; Mancuso, C.; Troiani, D.; Paludetti, G. Rosmarinic acid up-regulates the noise-activated Nrf2/HO-1 pathway and protects against noise-induced injury in rat cochlea. Free Radic. Biol. Med. 2015, 85, 269–281. [Google Scholar] [CrossRef] [PubMed]
- Kanner, J.; Selhub, J.; Shpaizer, A.; Rabkin, B.; Shacham, I.; Tirosh, O. Redox homeostasis in stomach medium by foods: The Postprandial Oxidative Stress Index (POSI) for balancing nutrition and human health. Redox Biol. 2017, 12, 929–936. [Google Scholar] [CrossRef]
- Lamothe, S.; Guérette, C.; Dion, F.; Sabik, H.; Britten, M. Antioxidant activity of milk and polyphenol-rich beverages during simulated gastrointestinal digestion of linseed oil emulsions. Food Res. Int. 2019, 122, 149–156. [Google Scholar] [CrossRef]
- Tullberg, C.; Vegarud, G.; Undeland, I. Oxidation of marine oils during in vitro gastrointestinal digestion with human digestive fluids – Role of oil origin, added tocopherols and lipolytic activity. Food Chem. 2019, 270, 527–537. [Google Scholar] [CrossRef]
- Pasko, P.; Barton, H.; Zagrodzki, P.; Izewska, A.; Krosniak, M.; Gawlik, M.; Gawlik, M.; Gorinstein, S. Effect of amaranth seeds in diet on oxidative status in plasma and selected tissues of high fructose-fed rats. Plant. Foods Hum. Nutr. 2010, 65, 146–151. [Google Scholar] [CrossRef]
- Cherkas, A.; Zarkovic, K.; Cipak Gasparovic, A.; Jaganjac, M.; Milkovic, L.; Abrahamovych, O.; Yatskevych, O.; Waeg, G.; Yelisyeyeva, O.; Zarkovic, N. Amaranth oil reduces accumulation of 4-hydroxynonenal-histidine adducts in gastric mucosa and improves heart rate variability in duodenal peptic ulcer patients undergoing Helicobacter pylori eradication. Free Radic. Res. 2018, 52, 135–149. [Google Scholar] [CrossRef]
- Boyd, O.; Weng, P.; Sun, X.P.; Alberico, T.; Laslo, M.; Obenland, D.M.; Kern, B.; Zou, S. Nectarine promotes longevity in Drosophila melanogaster. Free Radic. Biol. Med. 2011, 50, 1669–1678. [Google Scholar] [CrossRef] [Green Version]
- Zheng, R.J.; Dragomir, A.C.; Mishin, V.; Richardson, J.R.; Heck, D.E.; Laskin, D.L.; Laskin, J.D. Differential metabolism of 4-hydroxynonenal in liver, lung and brain of mice and rats. Toxicol. Appl. Pharm. 2014, 279, 43–52. [Google Scholar] [CrossRef] [Green Version]
- Huang, Y.; Li, W.; Kong, A.N. Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal. Cell Biosci. 2012, 2, 40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gross, B.; Pawlak, M.; Lefebvre, P.; Staels, B. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat. Rev. Endocrinol. 2017, 13, 36–49. [Google Scholar] [CrossRef] [PubMed]
- Cheng, R.; Ding, L.X.; He, X.M.; Takahashi, Y.; Ma, J.X. Interaction of PPAR alpha with the canonic Wnt pathway in the regulation of renal fibrosis. Diabetes 2016, 65, 3730–3743. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hosoi, T.; Kuwamura, A.; Thon, M.; Tsuchio, K.; Abd El-Hafeez, A.A.; Ozawa, K. Possible involvement of 4-hydroxy-2-nonenal in the pathogenesis of leptin resistance in obesity. Am. J. Physiol. Cell Physiol. 2019, 316, C641–C648. [Google Scholar] [CrossRef]
- Aslebagh, R.; Pfeffer, B.A.; Fliesler, S.J.; Darie, C.C. Mass spectrometry-based proteomics of oxidative stress: Identification of 4-hydroxy-2-nonenal (HNE) adducts of amino acids using lysozyme and bovine serum albumin as model proteins. Electrophoresis 2016, 37, 2615–2623. [Google Scholar] [CrossRef] [Green Version]
- Mendez, D.; Hernaez, M.L.; Diez, A.; Puyet, A.; Bautista, J.M. Combined proteomic approaches for the identification of specific amino acid residues modified by 4-hydroxy-2-nonenal under physiological conditions. J. Protome. Res. 2010, 9, 5770–5781. [Google Scholar] [CrossRef]
- Delosiere, M.; Sante-Lhoutellier, V.; Chantelauze, C.; Durand, D.; Thomas, A.; Joly, C.; Pujos-Guillot, E.; Remond, D.; Comte, B.; Gladine, C.; et al. Quantification of 4-hydroxy-2-nonenal-protein adducts in the in vivo gastric digesta of mini-pigs using a GC-MS/MS method with accuracy profile validation. Food Funct. 2016, 7, 3497–3504. [Google Scholar] [CrossRef]
- Colzani, M.; Criscuolo, A.; De Maddis, D.; Garzon, D.; Yeum, K.J.; Vistoli, G.; Carini, M.; Aldini, G. A novel high resolution MS approach for the screening of 4-hydroxy-trans-2-nonenal sequestering agents. J. Pharmaceut. Biomed. 2014, 91, 108–118. [Google Scholar] [CrossRef]
Medicinal Plants and Bioactive Compounds | Action/Mechanism | 4-HNE-Induced Model | References |
---|---|---|---|
Neuroprotection | |||
Polyphenol extract (red wine) | Inhibition of cleavage of PARP, reduction of ROS, protection against apoptosis | PC12 cells with apoptosis | [19] |
Quercetin Myricetin (red wine extract or G. biloba) | Cytoprotective effects | PC12 cell death | [19,20,21] |
Luteolin Apigenin (plant flavones) | Attenuation of cell death, caspase-3 and PARP-1 activation, mitigation of LC3 conversion and ROS production, activation of Nrf2 signaling | PC12 cells with cell viability | [22] |
Piceatannol (P. edulis or G. parvifolium) | Cytoprotective effect, restoration of PARP cleavage and Bcl-2 expression, down-regulation of p-JNK | PC12 cell death and nuclear condensation | [25] |
Citri reticulatae viride pericarpium | Anti-inflammation | PC12 cells with inflammatory injury | [27] |
Cocoa procyanidin fraction Procyanidin B2 | Attenuation of nuclear condensation, apoptotic cell death and ROS accumulation, blockade of MKK4 activity | PC12 cell death and nuclear condensation | [28] |
Trans-resveratrol (grapevinele) | Countering the cytotoxic response, attenuation of apoptotic neurodegeneration | PC12 cells with cytotoxicity | [30] |
Sulforaphane (crucifers such as broccoli, cabbages and olives) Carnosic acid (R. officinalis) | Increase of mitochondrial respiration Nrf2/ARE induction preventing against mitotoxic effect | Young adult male CF-1 mice Isolated cortical mitochondria with inhibition of mitochondrial respiration | [14] |
Kaempferol (flavonoid in many medicinal plants) | Suppression of apoptosis and p-JNK, inhibition of NOX activation | PC12 cells with apoptosis Neuron-like cells with NOX-mediated neurodegeneration | [13] |
Prevention of eye damage | |||
Berberine (C. chinesis) | Restoration of autophagy, inhibition of diabetic retinopathy | Confluent human retinal Müller cells with cell death | [55] |
Cyanidin-3-glucoside (plant fruits mulberry or L. caerulea) | Reduction of apoptosis ratio, inflammation and angiogenesis | ARPE-19 cells with apoptosis, inflammatory damage and angiogenesis | [12,63] |
Cyanidin-3-glucoside | Inhibition of NLRP3 inflammasome activation Regulation of JNK-c-Jun/AP-1 pathway | ARPE-19 cells with inflammation | [64] |
Quercetin | Anti-inflammation, improvement of cell membrane integrity and mitochondrial function, decrease of IL-6, IL-8 and MCP-1 production, regulation of MAPK pathway | ARPE-19 cells with cytotoxicity | [58,65] |
Protection of cardiovascular injury | |||
Oil of T. capitata | Prevention of cell death, mitochondrial membrane potential loss and ROS generation | Primary cultures of neonatal rat cardiomyocytes with cell death | [15] |
Ethanolic and methanolic extracts of olive leaf (O. europaea) | Inhibition of apoptosis, ROS production, viability impairment, mitochondrial dysfunction and pro-apoptotic activation, reduction of phosphorylation of stress-activated transcription factors | Rat cardiomyocytes with cell death | [68] |
Oleuropein Hydroxytyrosol Quercetin (olive leaf) | Prevention of carbonyl stress and toxicity, regulation of cellular redox status | Rat cardiomyocytes with cell death | [68] |
G. biloba leaf extract | Reduction of ox-LDL, attenuation of MMP-1 production, inhibition of the tyrosine-phosphorylated form of platelet-derived growth factor receptor beta activation | Human coronary smooth muscle cells with injury | [76] |
O. cladodes powder (containing phenolic acid and flavonoids) | Protection against toxicity | Normal (Apc +/+) and preneoplastic (Apc min/+) immortalized epithelial colon cells with toxicity | [77] |
Protection against liver injury | |||
Fine root extract of ginseng with ginsenosides profiles Methanolic extract of the main root | Inhibitory capacity against DNA damage | HepG2 cells with DNA damage | [80] |
Tanshinone II-A (S. miltiorrhiza) | Alleviation of hepatocyte damage up-regulation of PPARα, and scavenging 4-HNE | NCTC 1469 cells with damage | [85] |
7- Hydroxycoumain (C. lansium, P. forrestii, A. argyi, and P. purpurea) | Hepatoprotection via AKR7A2 induction | HepG2 cells with cytotoxicity | [90] |
Improvement of energy metabolism disorder | |||
Carnosic acid (R. officinalis) | Reduction of free fatty acid release, activation of pTyr632 IRS-1 and p-Akt, pSer307IRS-1, suppression of the PKA/HSL pathway activation, decrease of p-AMPK and acetyl-CoA carboxylase, alleviation of insulin resistance | 3T3-L1 adipocytes with insulin signaling impairment | [16] |
Carnosic acid | Attenuation of free fatty acid release, up-regulation of GST, reduction of 4-HNE-conjugated proteins attenuation of the lipolytic response | Human subcutaneous adipocytes with lipolysis | [16] |
4-Hydroxytyrosol (olive leaf) | Protection of red blood cells with oxidative damage | Hyperlipemic patients | [112] |
Repair of other disorders | |||
A. vera | Antioxidant capacity for the reduction of ROS and 4-HNE-protein adducts | HeLa, HMEC, HaCat, and HOS cells with over-production of ROS and -HNE-protein adducts | [113] |
Capsaicin (chili peppers) Curcumin (turmeric) Polyphenols G. biloba extract P. leucotomos extract | Inhibition of oxidative stress and cell apoptosis | Human melanocytes with oxidative stress and apoptosis | [116] |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wang, F.-X.; Li, H.-Y.; Li, Y.-Q.; Kong, L.-D. Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects? Biomolecules 2020, 10, 146. https://doi.org/10.3390/biom10010146
Wang F-X, Li H-Y, Li Y-Q, Kong L-D. Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects? Biomolecules. 2020; 10(1):146. https://doi.org/10.3390/biom10010146
Chicago/Turabian StyleWang, Fei-Xuan, Hong-Yan Li, Yun-Qian Li, and Ling-Dong Kong. 2020. "Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects?" Biomolecules 10, no. 1: 146. https://doi.org/10.3390/biom10010146
APA StyleWang, F. -X., Li, H. -Y., Li, Y. -Q., & Kong, L. -D. (2020). Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects? Biomolecules, 10(1), 146. https://doi.org/10.3390/biom10010146